scispace - formally typeset
E

Eugene Braunwald

Researcher at Brigham and Women's Hospital

Publications -  1758
Citations -  278949

Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.

TL;DR: Treatment with pravastatin over 5 years reduces all-cause mortality and coronary mortality in patients with and those without a history of coronary heart disease, and the size of the benefit was related principally to the baseline risk.
Journal ArticleDOI

Mechanism of increase of myocardial oxygen uptake produced by catecholamines.

TL;DR: It is concluded that while large doses of catecholamines can increase oxidative metabolism of the nonbeating heart by a small amount, the increases of MVo 2 produced by catechlamines in the beating heart are due in large part to the hemodynamic alterations which the amines induce.
Journal ArticleDOI

Prolonged abnormalities of myocardium salvaged by reperfusion.

TL;DR: Brief periods of myocardial ischemia are not associated with necrosis but result in functional, biochemical, and ultrastructural abnormalities, which are present for at lest 3 days after coronary reperfusion.
Journal ArticleDOI

Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (The MILIS study)

TL;DR: Patients with confirmed AMI diagnosed with cardiac arrest due to ventricular tachycardia or ventricular fibrillation in acute myocardial infarction had a higher mortality than patients in whom VT/VF occurred.
Journal ArticleDOI

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

TL;DR: Patients randomized to the LDE treated with amiodarone at the time of randomization demonstrated a significant reduction in ischaemic events vs. warfarin when compared with those not on amioarone, while preserving a favourable bleeding profile.